A case of rhabdomiolysis associated with raltegravir use
Authors:
- Luca DoriLDLuca Dori
- Anna R BuonominiABAnna R Buonomini
- Magda ViscioneMVMagda Viscione
- Loredana SarmatiLSLoredana Sarmati
- Massimo AndreoniMAMassimo Andreoni
- 28 January 2010
- journal article
- Published by Wolters Kluwer Health in AIDS
- Vol. 24 (3) , 473-475
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- RaltegravirDrugs, 2009
- Rhabdomyolysis in an HIV-Infected Patient on Anti-Retroviral Therapy Precipitated by High-Dose PravastatinCurrent Drug Safety, 2009
- Raltegravir: The first HIV integrase inhibitorClinical Therapeutics, 2008
- Raltegravir with Optimized Background Therapy for Resistant HIV-1 InfectionNew England Journal of Medicine, 2008
- Severe rhabdomyolysis associated with raltegravir useAIDS, 2008
- Raltegravir: an integrase inhibitor for HIV-1Expert Opinion on Investigational Drugs, 2008
- Antiretroviral Activity, Pharmacokinetics, and Tolerability of MK-0518, a Novel Inhibitor of HIV-1 Integrase, Dosed As Monotherapy for 10 Days in Treatment-Naive HIV-1-Infected IndividualsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006